Janssen Seeking Medicare Add-On Payments For CAR-T Carvykti, But CMS May Be Skeptical
Executive Summary
J&J will need to convince the Centers for Medicare and Medicaid Services that its treatment is not substantially similar to existing CAR-T’s in order to qualify for supplemental Medicare reimbursement.